Is cetirizine (hydrochloride) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cetirizine Hydrochloride Safety in Pregnancy

Cetirizine is safe to use during pregnancy and is recommended as a preferred second-generation antihistamine based on extensive safety data from large registries and cohort studies showing no increased risk of congenital malformations. 1

Primary Recommendation

The American College of Obstetricians and Gynecologists recommends cetirizine as a preferred second-generation antihistamine for use during pregnancy, with benefits of symptom control outweighing theoretical risks, particularly for moderate to severe allergic rhinitis. 1

  • Cetirizine is classified as FDA Pregnancy Category B, meaning no evidence of harm to the fetus exists, though well-controlled human studies are not available to exclude all harmful effects. 1
  • Large birth registries, case-control studies, and cohort studies confirm the safety of cetirizine during the first trimester. 1
  • The first trimester is the most critical period for medication-related congenital malformations, yet cetirizine has demonstrated safety even during organogenesis. 1

Supporting Safety Evidence

Multiple prospective studies demonstrate cetirizine's safety profile:

  • A prospective controlled study of 39 women exposed to cetirizine during organogenesis found no significant differences in rates of live births, spontaneous or therapeutic abortion, stillbirth, major or minor anomalies, birth weight, or neonatal distress compared to controls. 2
  • A Berlin teratology center cohort study of 196 first-trimester cetirizine exposures showed no increased risk of major birth defects (OR 1.07; CI 0.21-3.59), spontaneous abortions (OR 0.97; CI 0.54-1.65), or preterm deliveries (OR 0.76; CI 0.35-1.5). 3
  • UCB Pharma's safety database analysis of 228 pregnancies with cetirizine exposure reported 83.7% live births with only 2 congenital malformations among 41 live births, consistent with background rates. 4
  • A meta-analysis confirmed cetirizine is not associated with increased teratogenic risk. 5

Clinical Algorithm for Use

When managing allergic symptoms in pregnancy, follow this approach:

  1. Start with non-pharmacologic measures first: Use saline nasal rinses before adding cetirizine, as these have no fetal risk. 1

  2. Add cetirizine when symptoms persist: Use standard dosing when benefits of symptom control outweigh theoretical risks. 1

  3. For severe symptoms: Combine cetirizine with intranasal corticosteroids, particularly budesonide, which has strong safety data. 1

  4. Timing considerations: Cetirizine can be used throughout pregnancy, including the first trimester when organogenesis occurs. 1, 2, 3

Comparison to Alternative Antihistamines

Cetirizine and loratadine are the most well-studied second-generation antihistamines in pregnancy, making them preferable to newer agents with limited pregnancy data. 1

  • Avoid first-generation antihistamines like diphenhydramine due to lingering concerns about cleft palate association, plus sedative and anticholinergic properties. 1
  • Avoid levocetirizine as a first choice due to limited pregnancy data, despite being cetirizine's active enantiomer. 1
  • Second-generation antihistamines in general do not show significant increases in congenital malformations when used during the first trimester. 1

Important Caveats

The FDA drug label states to "ask a health professional before use" if pregnant, which reflects regulatory caution rather than evidence of harm. 6

  • This conservative labeling does not reflect the extensive post-marketing safety data demonstrating cetirizine's safety profile. 2, 4, 3, 5
  • No antihistamine has been categorized as definitively "safe" during pregnancy by regulatory standards, but cetirizine has the most robust safety evidence among second-generation agents. 7
  • Every medication carries theoretical teratogenic risk, but cetirizine's risk/benefit profile strongly favors use when clinically indicated. 7

What to Avoid

Do not use oral decongestants during the first trimester due to conflicting reports of associations with gastroschisis and small intestinal atresia. 1

References

Guideline

Antihistamine Use in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prospective controlled study of hydroxyzine and cetirizine in pregnancy.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1997

Research

Safety of cetirizine in pregnancy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2018

Research

The fetal safety of cetirizine: an observational cohort study and meta-analysis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2014

Research

A review of antihistamines used during pregnancy.

Journal of pharmacology & pharmacotherapeutics, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.